When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
4d
Sophie would make a world record for being the first man or woman with cystic fibrosis to row across the Atlantic, while at ...
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
Epicured Inc., an emerging health care company that develops, produces and distributes nutrition solutions to combat chronic disease and improve health outcomes, continues to expand its Life Sciences ...
No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.
If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...
Children whose cystic fibrosis is caused by a rare gene variant are excluded from a new treatment which could potentially ...
RTE Room to Improve viewers were moved to tears tonight as an old home was transformed into something “amazing” for Cystic ...
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback